PT Jayamas Medica Industri Tbk (IDX: OMED)
181.00
+2.00 (1.12%)
Sep 10, 2024, 3:48 PM WIB
OMED Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 292,696 | 259,360 | 285,782 | 562,692 | 685,510 | 226,208 |
Depreciation & Amortization | 58,121 | 56,526 | 41,214 | 34,973 | 16,892 | 13,608 |
Other Amortization | 465.39 | 427.87 | 431.79 | 659.37 | 1,216 | - |
Other Operating Activities | 59,189 | -181,959 | -234,810 | -93,216 | -424,884 | -65,098 |
Operating Cash Flow | 410,472 | 134,354 | 92,617 | 505,108 | 278,735 | 174,718 |
Operating Cash Flow Growth | 798.53% | 45.06% | -81.66% | 81.21% | 59.53% | - |
Capital Expenditures | -126,955 | -156,385 | -75,068 | -82,722 | -49,963 | -14,494 |
Sale of Property, Plant & Equipment | 408.65 | 409.94 | 0.35 | 38.36 | 2,608 | 109.7 |
Sale (Purchase) of Intangibles | -75.51 | -56.12 | -302.25 | -61.94 | -2,482 | - |
Investment in Securities | -47,947 | 420,440 | -419,477 | -104,310 | -5 | -690 |
Other Investing Activities | 185.15 | 185.15 | -251.91 | - | - | - |
Investing Cash Flow | -174,384 | 264,594 | -495,100 | -187,056 | -49,842 | -15,074 |
Long-Term Debt Issued | - | - | - | - | 159,200 | - |
Long-Term Debt Repaid | - | -25,307 | -36,342 | -17,972 | -2,875 | -1,694 |
Net Debt Issued (Repaid) | -34,773 | -25,307 | -36,342 | -17,972 | 156,325 | -1,694 |
Issuance of Common Stock | - | - | 780,579 | - | - | - |
Repurchase of Common Stock | - | - | - | - | -5,500 | - |
Common Dividends Paid | - | -85,777 | -250,000 | -255,000 | - | - |
Other Financing Activities | - | 505 | -750 | -10,000 | - | - |
Financing Cash Flow | -34,773 | -110,578 | 493,486 | -282,972 | 150,825 | -1,694 |
Foreign Exchange Rate Adjustments | 17,748 | 1,654 | 6,704 | 731.57 | 1,097 | -38.16 |
Net Cash Flow | 219,063 | 290,023 | 97,708 | 35,812 | 380,815 | 157,911 |
Free Cash Flow | 283,516 | -22,031 | 17,549 | 422,386 | 228,771 | 160,224 |
Free Cash Flow Growth | - | - | -95.85% | 84.63% | 42.78% | - |
Free Cash Flow Margin | 15.70% | -1.27% | 1.01% | 18.97% | 11.47% | 13.05% |
Free Cash Flow Per Share | 10.48 | -0.81 | 0.65 | 15.61 | 8.33 | 3.13 |
Cash Interest Paid | 17,272 | 16,957 | 16,952 | 17,138 | 8,550 | 146.62 |
Cash Income Tax Paid | 71,922 | 76,907 | 193,043 | 142,710 | 32,617 | 26,797 |
Levered Free Cash Flow | 265,306 | -91,618 | 8,156 | 311,711 | 358,952 | - |
Unlevered Free Cash Flow | 277,657 | -79,380 | 21,159 | 325,362 | 364,582 | - |
Change in Net Working Capital | -145,257 | 167,939 | 177,768 | 85,509 | 132,011 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.